Suppr超能文献

KLF4 周转率的调节揭示了 pVHL 在肿瘤发生中具有意想不到的组织特异性作用。

Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis.

机构信息

Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.

出版信息

Mol Cell. 2012 Jan 27;45(2):233-43. doi: 10.1016/j.molcel.2011.11.031.

Abstract

The transcription factor Krüppel-like factor 4 (KLF4) is an important regulator of cell-fate decision, including cell-cycle regulation, apoptosis, and stem cell renewal, and plays an ambivalent role in tumorigenesis as a tissue-specific tumor suppressor or oncogene. Here, we report that the Von Hippel-Lindau gene product, pVHL, physically interacts with KLF4 and regulates its rapid turnover observed in both differentiated and stem cells. We provide mechanistic insights into KLF4 degradation and show that pVHL depletion in colorectal cancer cells leads to cell-cycle arrest concomitant with increased transcription of the KLF4-dependent p21 gene. Finally, immunohistochemical staining revealed elevated pVHL and reduced KLF4 levels in colon cancer tissues. We therefore propose that unexpectedly pVHL, via the degradation of KLF4, is a facilitating factor in colorectal tumorigenesis.

摘要

转录因子 Krüppel 样因子 4(KLF4)是细胞命运决定的重要调节剂,包括细胞周期调节、细胞凋亡和干细胞更新,并在肿瘤发生中作为组织特异性肿瘤抑制因子或癌基因发挥双重作用。在这里,我们报告称,Von Hippel-Lindau 基因产物 pVHL 与 KLF4 物理相互作用,并调节其在分化细胞和干细胞中观察到的快速周转。我们提供了 KLF4 降解的机制见解,并表明在结直肠癌细胞中耗尽 pVHL 会导致细胞周期停滞,同时增加 KLF4 依赖性 p21 基因的转录。最后,免疫组织化学染色显示结肠癌组织中 pVHL 升高和 KLF4 水平降低。因此,我们提出,出乎意料的是,pVHL 通过降解 KLF4,是结直肠肿瘤发生的促进因素。

相似文献

1
Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis.
Mol Cell. 2012 Jan 27;45(2):233-43. doi: 10.1016/j.molcel.2011.11.031.
2
Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis.
J Biol Chem. 2012 Apr 20;287(17):13584-97. doi: 10.1074/jbc.M112.343566. Epub 2012 Mar 2.
3
Overexpression of KLF4 promotes cell senescence through microRNA-203-survivin-p21 pathway.
Oncotarget. 2016 Sep 13;7(37):60290-60302. doi: 10.18632/oncotarget.11200.
4
Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.
J Exp Clin Cancer Res. 2019 Jan 18;38(1):23. doi: 10.1186/s13046-019-1034-1.
5
FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Oncogene. 2017 Jun 8;36(23):3312-3321. doi: 10.1038/onc.2016.479. Epub 2017 Jan 9.
6
Epigallocatechin-3-gallate regulates the expression of Kruppel-like factor 4 through myocyte enhancer factor 2A.
Cell Stress Chaperones. 2014 Mar;19(2):217-26. doi: 10.1007/s12192-013-0447-6. Epub 2013 Jul 25.
8
Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma.
Clin Cancer Res. 2009 Sep 15;15(18):5688-95. doi: 10.1158/1078-0432.CCR-09-0310. Epub 2009 Sep 8.
9
Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor.
Oncogene. 2011 Jan 6;30(1):21-31. doi: 10.1038/onc.2010.395. Epub 2010 Aug 30.

引用本文的文献

2
KLF feedback loops in innate immunity.
Front Immunol. 2025 Jun 4;16:1606277. doi: 10.3389/fimmu.2025.1606277. eCollection 2025.
3
Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality.
Genes Dis. 2024 Apr 17;12(3):101311. doi: 10.1016/j.gendis.2024.101311. eCollection 2025 May.
4
Role of PRMT1 and PRMT5 in Breast Cancer.
Int J Mol Sci. 2024 Aug 14;25(16):8854. doi: 10.3390/ijms25168854.
5
Epsins oversee smooth muscle cell reprograming by influencing master regulators KLF4 and OCT4.
bioRxiv. 2024 Aug 26:2024.01.08.574714. doi: 10.1101/2024.01.08.574714.
6
VHL suppresses UBE3B-mediated breast tumor growth and metastasis.
Cell Death Dis. 2024 Jun 24;15(6):446. doi: 10.1038/s41419-024-06844-x.
7
Pooled multicolour tagging for visualizing subcellular protein dynamics.
Nat Cell Biol. 2024 May;26(5):745-756. doi: 10.1038/s41556-024-01407-w. Epub 2024 Apr 19.
8
Therapeutic Targeting of Krüppel-Like Factor 4 and Its Pharmacological Potential in Parkinson's Disease: a Comprehensive Review.
Mol Neurobiol. 2024 Jun;61(6):3596-3606. doi: 10.1007/s12035-023-03800-2. Epub 2023 Nov 24.
9
Amplifications and Metabolic Rewiring in Neuroblastoma.
Cancers (Basel). 2023 Sep 29;15(19):4803. doi: 10.3390/cancers15194803.
10
Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease.
Cell Death Dis. 2023 Oct 13;14(10):680. doi: 10.1038/s41419-023-06185-1.

本文引用的文献

1
VHL loss causes spindle misorientation and chromosome instability.
Nat Cell Biol. 2009 Aug;11(8):994-1001. doi: 10.1038/ncb1912. Epub 2009 Jul 20.
2
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.
Nat Rev Cancer. 2008 Nov;8(11):865-73. doi: 10.1038/nrc2502. Epub 2008 Oct 16.
3
Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells.
Proteomics. 2008 Jul;8(14):2885-96. doi: 10.1002/pmic.200700887.
4
Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells.
Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):554-64. doi: 10.1111/j.1745-7270.2008.00439.x.
6
Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor.
Biochem Soc Trans. 2008 Jun;36(Pt 3):472-8. doi: 10.1042/BST0360472.
7
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400.
Nat Cell Biol. 2008 Mar;10(3):361-9. doi: 10.1038/ncb1699. Epub 2008 Feb 24.
8
Von Hippel-Lindau disease.
Annu Rev Pathol. 2007;2:145-73. doi: 10.1146/annurev.pathol.2.010506.092049.
9
Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity.
Nucleic Acids Res. 2007;35(18):6137-49. doi: 10.1093/nar/gkm656. Epub 2007 Sep 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验